The Genetics of COVID-19
In this webinar, Nick Lench, PhD, reviews the current state of knowledge regarding the genetics of COVID-19 and the potential application of pharmacogenetics to patient management and clinical trials. Dr Lench also describes the development of a Congenica COVID-19 application that enables the analysis of a patient’s genome data to identify clinically actionable DNA variants.
About our speaker
Nick Lench, PhD FRCPath, Chief Scientific Officer of Congenica
Chief Scientific Officer and one of the founders of Congenica, Nick was previously Director of the Regional Genetics Service at Great Ormond Street Hospital in London and has over 25 years of academic, healthcare and commercial experience in medical genetics and genomics.